MedPath

Analgesic Effect of Breastmilk for Procedural Pain in Preterm Infants

Phase 3
Conditions
Procedural Pain
Interventions
Other: Oral Sucrose
Other: Breastmilk
Registration Number
NCT00908401
Lead Sponsor
Centre Hospitalier Intercommunal Creteil
Brief Summary

Hypothesis: Breastmilk has a more powerful analgesic effect than oral sucrose to avoid procedural pain in preterm neonates.

The objective is to test this hypothesis in a randomized, controlled study using a standardized and validated pain scale (DAN). The sample size is 21 preterm infants in each two groups. The main end point is a reduction of the risk to have a DAN superior to 1 from 80% with oral sucrose to 40% with breastmilk.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
42
Inclusion Criteria
  • preterm neonates born before 27 and 29+6 weeks GA
  • blood sampling procedure
  • obtention of parental consent
Exclusion Criteria
  • congenital malformation
  • intravenous continuous analgesia
  • contraindications to feed
  • high grade intracerebral hemorrhage

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
sucroseOral SucroseThis group will receive oral sucrose for procedural pain
breastmilkBreastmilkthis group will receive breastmilk as analgesic product to avoid procedural pain
Primary Outcome Measures
NameTimeMethod
Decrement from 80 to 40% of frequency of DAN's scale score superior to 1 using breastmilk instead of oral sucroseOne time during day 3 or 4 then day 7 to 10
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Hospitalier Intercommunal de Creteil

🇫🇷

Creteil, France

© Copyright 2025. All Rights Reserved by MedPath